Evidence map›Paper›PMID 10364415›Full record

ArticlePlant physiology1999

Gibberellin dose-response curves and the characterization of dwarf mutants of barley

Chandler, Robertson

Open access · bronzeAbstract read
In one paragraph

Article in Plant physiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 94 citations in OpenAlex.

  1. INDETERMINATE DOMAIN-DELLA protein interactions orchestrate gibberellin-mediated cell elongation in wheat and barley.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Have All of the Phytohormonal Properties of Melatonin Been Verified?International journal of molecular sciences · 2024
    Review
  3. Article
  4. Gibberellin Signaling RepressorInternational journal of molecular sciences · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Plant physiology · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

ChandlerCommonwealth Scientific and Industrial Research Organization Plant Industry, G.P.O. Box 1600, Canberra, ACT 2601, Australia.
Robertson
Plant Industry · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dose-response curves relating gibberellin (GA) concentration to the maximal leaf-elongation rate (LERmax) defined three classes of recessive dwarf mutants in the barley (Hordeum vulgare L.) 'Himalaya. ' The first class responded to low (10(-8)-10(-6) M) [GA3] (as did the wild type). These grd (GA-responsive dwarf) mutants are likely to be GA-biosynthesis mutants. The second class of mutant, gse (GA sensitivity), differed principally in GA sensitivity, requiring approximately 100-fold higher [GA3] for both leaf elongation and alpha-amylase production by aleurone. This novel class may have impaired recognition between the components that are involved in GA signaling. The third class of mutant showed no effect of GA3 on the LERmax. When further dwarfed by treatment with a GA-biosynthesis inhibitor, mutants in this class did respond to GA3, although the LERmax never exceeded that of the untreated dwarf. These mutants, called elo (elongation), appeared to be defective in the specific processes that are required for elongation rather than in GA signaling. When sln1 (slender1) was introduced into these different genetic backgrounds, sln was epistatic to grd and gse but hypostatic to elo. Because the rapid leaf elongation typical of sln was observed in the grd and gse backgrounds, we inferred that rapid leaf elongation is the default state and suggest that GA action is mediated through the activity of the product of the Sln gene.

Identifiers

PMID10364415
PMCPMC59302
OpenAlexW2054722567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.